Lee, Matthew M. Y. http://orcid.org/0000-0001-9213-2067
Lean, Michael E. J. http://orcid.org/0000-0003-2216-0083
Sattar, Naveed http://orcid.org/0000-0002-1604-2593
Petrie, Mark C. http://orcid.org/0000-0002-6333-9496
Article History
Accepted: 13 November 2023
First Online: 22 December 2023
Declarations
:
: Lee received research grants through his institution, the University of Glasgow, from AstraZeneca, Boehringer Ingelheim, and Roche Diagnostics; is a member of a Trial Steering Committee for Cytokinetics, and Clinical Endpoints Committee for Bayer.Lean declares personal fees for lecturing from Novo Nordisk, Nestle, and Eli Lilly; and departmental funding support for research and consultancy from Novo Nordisk, Counterweight Ltd, Diabetes UK, All Saints Educational Trust, and NIHR.Sattar received consulting/speaker honoraria from Abbott Laboratories, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, and Sanofi; received grants from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics.Petrie received research funding from Boehringer Ingelheim, Roche, SQ Innovations, AstraZeneca, Novartis, Novo Nordisk, Medtronic, Boston Scientific, Pharmacosmos; participation in Consultancy and Trial committees for Akero, Applied Therapeutics, AnaCardio, Biosensors, Boehringer Ingelheim, Novartis, AstraZeneca, Novo Nordisk, Abbvie, Bayer, Horizon Therapeutics, Takeda, Cardiorentis, Pharmacosmos, Siemens, Eli Lilly, Vifor, New Amsterdam, Moderna, and Teikoku.
: All reported studies with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards and international/national/institutional guidelines).